1Anderson R,Theron AJ,Feldman C. Membrane-stabilizing,anti-inflammatory. interactions of macmlides with human neutrophils[J]. Inflammation,1996,20(6):693-705. 被引量：1
2Jorgensen JH,Weigel LM,Swenson JM,et al. Activities of clinafloxacin, gatifloxacin, gemifoxacin and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae[J]. Antimicrob Agents Chemother, 2000,44 : 2962-2968. 被引量：1
3Erikci AA,Ozturk A,Karagoz B,et al. Results of combination therapy with amifostine,pentoxifylline,ciprofloxaein and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia [J]. Hematology, 2008,13 ( 5 ) : 289-292. 被引量：1
4Kerawala M,Ambler JE,Lee PYC,et al. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against Streptococcal isolates,excluding Streptococcus pneumoniae[J]. Eur J Clin Microbiol Infect Dis, 2001,20(4) : 271-275. 被引量：1
5Shaw PJ, Ganey PE, Roth RA. Tumor necrosis factor alpha is a proximal mediator of synergistic hepatotoxicity from trovafloxacin/lipopolysaccharide coexposure[J]. J Pharmacol Exp Ther, 2009,328( 1 ):62-68. 被引量：1
6Lopez H,Stepanik D,Vilches V,et al. Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates from Argentina[J]. Diagnostic Microbial Infect Dis,2001,40: 187-192. 被引量：1
7Kleinkauf N, Ackermann G, Schaumann R, et al. Comparative in vitro activities of gemifloxacin, other quinolones and non-quniolones antimicrobials against obligately anaerobic bacteria[J]. Antimicrob Agents Chem other, 2001,45 : 1896-1899. 被引量：1
